The agreement outlines a framework for all transportation and supply chain services that will be needed to deliver COVAXX’s vaccine candidate UB-612 worldwide, once approved by regulatory authorities. COVAXX is currently developing UB-612 through a high precision, synthetic peptide platform that activates both B-cell and T-cell arms. The investigational vaccine has been manufactured to replicate […]

When Japan’s landmark regenerative medicine legislation took effect in 2014, it opened an entirely new market for biotech innovators. Athersys, a leader in regenerative medicine, seized the opportunity. Athersys’s MultiStem® cell therapy is in Phase III clinical trials in the U.S., and with Japanese partner Healios K.K. in Japan, to treat ischemic stroke and acute […]

Maersk has entered a partnership with manufacturer Covaxx for the distribution of its COVID-19 vaccine — which is currently in phase 1 clinical trials — once it is approved by regulatory authorities, according to an announcement Monday from the logistics company. The agreement between the two companies lays out a plan for the end-to-end supply […]